Esperion Therapeutics, Ann Arbor SPARK CEO Podcast

Roger Newton is Executive Chairman and Chief Scientific Officer of Esperion Therapeutics Tim Mayleben is President and Chief Executive Officer of Esperion Therapeutics Esperion Therapeutics is a clinical stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density, lipoprotein cholesterol (LDL-C) lowering therapies for treatment of hypercholesterolemia and other cardiometabolic risk markers. In their... [Read More...]